ARCALIS CEO Takamatsu will present at Bio Japan 2024 Organizer’s Seminar
We are pleased to announce that our CEO, Satoshi Takamatsu, will be speaking at the Organizer’s Seminar during “BioJapan 2024” which will be held from October 9th (Wed.) to 11th (Fri.), 2024, at PACIFICO Yokohama. ARCALIS will also have a corporate exhibition booth throughout the event. We look forward to welcoming you to our booth and seminar.
【Event Details】 https://jcd-expo.jp/en/
【Booth Information】
Date: October 9th (Wed.) – 11th (Fri.)
Venue: PACIFICO Yokohama, Exhibition Hall C-1
【Corporate Seminar】
Date: October 11th (Fri.) 10:00 AM – 11:30 AM
Venue: PACIFICO Yokohama, Annex Hall F203
Title: Challenges and Opportunities in mRNA Pharmaceuticals
Our Presentation Topic: GMP Manufacturing and Quality Control of mRNA drugs
Abstract: We will discuss the challenges and potential of mRNA, which is attracting attention from a regulatory perspective. Our Representative Director, President and CEO, Satoshi Takamatsu, will be joined by three other leading figures in the field of mRNA pharmaceuticals.